Flagship-backed startup aims to ‘close off the escape routes’ for evolving viruses

A new startup funded by Flagship Pioneering is trying to succeed where others have failed: It’s aiming to use artificial intelligence to develop "variant-proof" vaccines and antibodies against viruses.